Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Retina (Philadelphia, Pa.)
|
August 19, 2000
Phototoxicity from systemic sodium fluorescein
R P Danis, S Wolverton, T Steffens
Cancer Research
|
August 1, 1992
DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors
J S Wolverton, M K Danks, B Granzen, et al.
Journal of Experimental Psychology. Human Perception and Performance
|
April 1, 1985
Some temporal characteristics of processing during reading
G W McConkie, N R Underwood, D Zola, et al.
Journal of Experimental Psychology. Human Perception and Performance
|
February 1, 1984
Time course of visual information utilization during fixations in reading
H E Blanchard, G W McConkie, D Zola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure
M K Danks, C A Pawlik, D O Whipple, et al.
Cancer Research
|
May 1, 1989
Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells
J S Wolverton, M K Danks, C A Schmidt, et al.
Cancer Research
|
August 29, 1998
Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme
P M Potter, J S Wolverton, C L Morton, et al.
Cytometry
|
July 17, 1998
In situ subcellular localization of epitope-tagged human and rabbit carboxylesterases
P M Potter, J S Wolverton, C L Morton, et al.
Cancer Research
|
October 15, 1987
Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells
W T Beck, M C Cirtain, M K Danks, et al.
Cytotechnology
|
January 1, 1993
Altered DNA topoisomerase II in multidrug resistance
W T Beck, M K Danks, J S Wolverton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Retina (Philadelphia, Pa.)
|
August 19, 2000
Phototoxicity from systemic sodium fluorescein
R P Danis, S Wolverton, T Steffens
Cancer Research
|
August 1, 1992
DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors
J S Wolverton, M K Danks, B Granzen, et al.
Journal of Experimental Psychology. Human Perception and Performance
|
April 1, 1985
Some temporal characteristics of processing during reading
G W McConkie, N R Underwood, D Zola, et al.
Journal of Experimental Psychology. Human Perception and Performance
|
February 1, 1984
Time course of visual information utilization during fixations in reading
H E Blanchard, G W McConkie, D Zola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure
M K Danks, C A Pawlik, D O Whipple, et al.
Cancer Research
|
May 1, 1989
Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells
J S Wolverton, M K Danks, C A Schmidt, et al.
Cancer Research
|
August 29, 1998
Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme
P M Potter, J S Wolverton, C L Morton, et al.
Cytometry
|
July 17, 1998
In situ subcellular localization of epitope-tagged human and rabbit carboxylesterases
P M Potter, J S Wolverton, C L Morton, et al.
Cancer Research
|
October 15, 1987
Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells
W T Beck, M C Cirtain, M K Danks, et al.
Cytotechnology
|
January 1, 1993
Altered DNA topoisomerase II in multidrug resistance
W T Beck, M K Danks, J S Wolverton, et al.
Page
of 2